Fennec Pharmaceuticals (NASDAQ: FENC) reported Q2 EPS of ($0.11), $0.07 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $9.65 million versus the consensus estimate of $9.39 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.